Medication Adherence to Semaglutide Once-Weekly Injection Among Type-2 Diabetes Patients in Tabuk, Saudi Arabia – A Cross-Sectional Study
Patient Preference and Adherence · 2025-08 · Volume 19 · 2535-2551
DOI: 10.2147/ppa.s534534 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Patient Preference and Adherence, 2025-08. Verfasst von Palanisamy Amirthalingam und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Semaglutide, a once-weekly injection (SOWI), is a glucagon-like peptide-1 receptor agonist for managing type-2 diabetes (T2D). However, it has a high discontinuation rate among users in the first year after treatment initiation. This study investigated the medication adherence level among T2D patients managed with SOWI.
Methods
This cross-sectional study was conducted among T2D patients aged 18 years or above who visited the outpatient pharmacy to refill their prescriptions for SOWI. The patients responded to their sociodemographic characteristics and the Adherence to Refills and Medications Scale (ARMS). The patient's electronic health record obtained details of the proportion of days covered (PDC), glycosylated hemoglobin (HbA1C), and body mass index (BMI). The association of medication adherence and sociodemographic characteristics, as well as the clinical outcomes between patients with different levels of adherence, were analyzed.
Results
A total of 434 patients were included in this study. According to the ARMS score, only 32.48% (141) of the patients adhered to SOWI. Sociodemographic characteristics had lower odds association for medication non-adherence. However, non-adherent patients had a significant association with BMI (overweight and obese) and HbA1C (>7). The adherence level of PDC for SOWI was significantly associated with the ARMS medication adherence level. The mean HbA1C and BMI between adherents and non-adherents were statistically significant (p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
- King Salman Armed Forces Hospital, Northwestern Region, Tabuk, Saudi Arabia.
- Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
- Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
ORCID-Profile: Palanisamy Amirthalingam, Ahmed Mohsen Elsaid Hamdan, Ahmed Aljabri, Saleh Alqifari, Hanan Alshareef, Mostafa A Sayed Ali
Zitieren
APA
Amirthalingam, P., Alatawi, O. S., Hamdan, A. M. E., Aljabri, A., Alqifari, S., Alshareef, H., Hakami, F. A. M., Albalawi, N. S., A Albrahimi, H. M., Mubark Alanazi, S. M., Alatawi, A. M., Albalwi, A. A. S., & Ali, M. A. S. (2025). Medication Adherence to Semaglutide Once-Weekly Injection Among Type-2 Diabetes Patients in Tabuk, Saudi Arabia – A Cross-Sectional Study. Patient Preference and Adherence, Volume 19, 2535-2551. https://doi.org/10.2147/ppa.s534534
Vancouver
Amirthalingam P, Alatawi OS, Hamdan AME, Aljabri A, Alqifari S, Alshareef H, et al. Medication Adherence to Semaglutide Once-Weekly Injection Among Type-2 Diabetes Patients in Tabuk, Saudi Arabia – A Cross-Sectional Study. Patient Preference and Adherence. 2025;Volume 19:2535-2551. doi:10.2147/ppa.s534534
BibTeX
@article{Amirthalingam2025,
author = {Amirthalingam, Palanisamy and Alatawi, Olayan Salamah and Hamdan, Ahmed Mohsen Elsaid and Aljabri, Ahmed and Alqifari, Saleh and Alshareef, Hanan and Hakami, Faris Ahmed M and Albalawi, Nader Salem and A Albrahimi, Hazem Moufeed and Mubark Alanazi, Sultan Mohammed and Alatawi, Ahmed Mutair and Albalwi, Abdullah Abdalziz S and Ali, Mostafa A Sayed},
title = {Medication Adherence to Semaglutide Once-Weekly Injection Among Type-2 Diabetes Patients in Tabuk, Saudi Arabia – A Cross-Sectional Study},
journal = {Patient Preference and Adherence},
year = {2025},
volume = {Volume 19},
pages = {2535--2551},
doi = {10.2147/ppa.s534534}
}
EUVIMED